SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company witnessed a 5.09% growth in the revenue at Rs. 2360.60 millions for the quarter ended September 2024 as compared to Rs. 2246.20 millions during the year-ago period.Net profit for the quarter ended September 2024 increases to Rs. 763.30  millions from Rs. 747.30 millions.OP of the company witnessed a marginal growth to 1144.40 millions from 1122.40 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 2360.60 2246.20 5.09 4581.50 5686.50 -19.43 10249.93 13300.80 -22.94
Other Income 134.30 142.00 -5.42 313.80 242.60 29.35 550.93 445.52 23.66
PBIDT 1144.40 1122.40 1.96 2154.30 2929.70 -26.47 4649.93 6352.40 -26.80
Interest 14.70 11.40 28.95 30.70 30.00 2.33 74.27 127.48 -41.74
PBDT 1129.70 1111.00 1.68 2123.60 2899.70 -26.76 4575.66 6224.92 -26.49
Depreciation 122.90 105.30 16.71 242.90 217.50 11.68 487.92 430.99 13.21
PBT 1006.80 1005.70 0.11 1880.70 2682.20 -29.88 4087.74 5793.93 -29.45
TAX 243.50 258.40 -5.77 466.60 691.90 -32.56 1039.59 1467.91 -29.18
Deferred Tax -35.60 15.50 -329.68 -12.60 35.90 -135.10 65.92 43.38 51.96
PAT 763.30 747.30 2.14 1414.10 1990.30 -28.95 3048.15 4326.02 -29.54
Equity 254.60 254.60 0.00 254.60 254.60 0.00 254.57 254.57 0.00
PBIDTM(%) 48.48 49.97 -2.98 47.02 51.52 -8.73 45.37 47.76 -5.01

Cohance Lifesciences Share Price

365.50 3.60 (0.99%)
22-Apr-2026 11:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.85
Dr. Reddys Lab 1220.20
Cipla 1231.15
Zydus Lifesciences 930.70
Lupin 2313.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×